Open Public Comment

Open public comment periods allow key stakeholders to review guideline draft recommendation statements to help identify any errors or gaps prior to publication. This best practice guideline development process allows for greater transparency and complies with the National Academy of Medicine (formerly the Institute of Medicine) standards. Open public comment additionally enables AMP to engage with a diverse group of interested stakeholders around the world, provide a higher-quality product to the AMP membership, and facilitate guideline implementation and dissemination efforts.

AMP Guidelines are available for a 2- to 3-week open comment period. Individual reviewers submit their comments anonymously through a SurveyMonkey form. An alternate form may be available for organizations to submit their comments. All comments are reviewed and considered by the subject matter expert guideline development panel. Any changes made to the draft recommendations from the open comment process will be reviewed and approved by the guideline panel. Comments are advisory only and AMP is not required to make any changes based on feedback from open comment. AMP will not respond to reviewers or post responses to comments.